Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
315.5 INR | +2.45% | +1.15% | +26.38% |
07:14am | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
17/05 | Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.38% | 441.58Cr | |
+10.44% | 12TCr | |
+12.10% | 11TCr | |
-4.45% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-13.77% | 1.76TCr | |
-40.50% | 1.73TCr | |
+5.95% | 1.4TCr | |
+30.69% | 1.21TCr |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico